Skip to main content
Nature Communications logoLink to Nature Communications
. 2024 Apr 24;15:3448. doi: 10.1038/s41467-024-47775-7

Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

Mike B Barnkob 1,8,, Yale S Michaels 2,9,10, Violaine André 1, Philip S Macklin 3, Uzi Gileadi 1, Salvatore Valvo 4, Margarida Rei 1,11, Corinna Kulicke 1,12, Ji-Li Chen 1, Vitul Jain 5, Victoria K Woodcock 1, Huw Colin-York 1, Andreas V Hadjinicolaou 1,13,14, Youxin Kong 5, Viveka Mayya 4, Julie M Mazet 4, Gracie-Jennah Mead 4, Joshua A Bull 6, Pramila Rijal 1, Christopher W Pugh 3, Alain R Townsend 1, Audrey Gérard 4, Lars R Olsen 7, Marco Fritzsche 1,4, Tudor A Fulga 2, Michael L Dustin 4, E Yvonne Jones 5,, Vincenzo Cerundolo 1
PMCID: PMC11043410  PMID: 38658563

Correction to: Nature Communications 10.1038/s41467-024-47424-z, published online 12 April 2024

In this article the title was incorrectly written as ‘Semmaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells’ but should have been ‘Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells’. The original article has been corrected.

Contributor Information

Mike B. Barnkob, Email: mike.bogetofte.barnkob@rsyd.dk

E. Yvonne Jones, Email: yvonne@strubi.ox.ac.uk.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES